Below are the most recent publications written about "Chikungunya virus" by people in Profiles.
-
Rahat MA, Makhaik S, Hardy JA. Assessing Chikungunya Virus Protease Activity and Pharmacological Inhibition Using the acc-CHIK15-dnp Fluorogenic Peptide Substrate. Methods Mol Biol. 2027; 3067:125-147.
-
Makhaik S, Rut W, Choudhary S, Upadhyay T, Hao C, Westberg M, Bobst C, Yoo E, Fejzo J, Lin MZ, Bogyo M, Thompson P, Drag M, Hardy JA. A robust fluorogenic substrate for chikungunya virus protease (nsP2) activity. Protein Sci. 2025 03; 34(3):e70069.
-
Yoon IK, Srikiatkhachorn A, Alera MT, Fernandez S, Cummings DAT, Salje H. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort. Int J Infect Dis. 2020 Jun; 95:167-173.
-
Golding J, Wacks J. Subacute polyarticular arthralgias · swelling of the ankles and right knee · recent travel to the Dominican Republic · Dx? J Fam Pract. 2019 04; 68(3):171;172;174.
-
Bustos Carrillo F, Collado D, Sanchez N, Ojeda S, Lopez Mercado B, Burger-Calderon R, Gresh L, Gordon A, Balmaseda A, Kuan G, Harris E. Epidemiological Evidence for Lineage-Specific Differences in the Risk of Inapparent Chikungunya Virus Infection. J Virol. 2019 02 15; 93(4).
-
Srikiatkhachorn A, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG, Nisalak A, Macareo LR, Yoon IK. Resolution of a Chikungunya Outbreak in a Prospective Cohort, Cebu, Philippines, 2012-2014. Emerg Infect Dis. 2016 10; 22(10):1852-4.
-
Carter JR, Taylor S, Fraser TS, Kucharski CA, Dawson JL, Fraser MJ. Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domain. PLoS One. 2015; 10(11):e0139899.
-
Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG, Salje H, Macareo LR, Hermann LL, Nisalak A, Srikiatkhachorn A. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl Trop Dis. 2015 May; 9(5):e0003764.
-
Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis. 2011 Oct 01; 204(7):1026-30.